Study exposes lack of diversity in US cancer trials

July 05, 2022

A recent article by PharmaPhorum explored the results of a Phesi study that exposed the lack of diversity in US cancer trials. PharmaPhorum spoke with Otis Johnson, Ph.D., M.P.A., Clario’s Chief Diversity, Inclusion & Sustainability Officer, for insight on the report. Read the full article here.